An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum

ProCAncer-I in the IEEE-MeMeA Conference in Taormina

Published on: June 17, 2022
Categories: News
We are looking forward to participating it the upcoming IEEE-MeMeA Conference in Taormina! The 17th edition of IEEE International Symposium on Medical Measurements and Applications will take place in Giardini Naxos, Taormina in the metropolitan area of Messina, Italy, from June 22nd to 24th.
Dr. Valentina Giannini (FPO) and Dr. João Santinha (FCHAMP) will chair a special session (no.14) entitled “AI-POWERED MEDICAL IMAGE ANALYSIS: RADIOMICS FOR PERSONALIZED PATIENTS’ MANAGEMENT” (https://memea2022.ieee-ims.org/special-sessons/). The session is designed to cover all aspects related to the development of AI-based imaging biomarkers and techniques, for personalizing management of patients and including the challenges which need to be addressed before translation of AI to clinical use, as explainability of the models, reproducibility of quantitative imaging features, sensitivity of the results to image acquisition and reconstruction parameters. In this special session, Dr. Giovanni Maimone (FPO) will present a study entitled “Comparison of Machine and Deep Learning models for automatic segmentation of prostate cancers on multiparametric MR” acknowledging the Pro-Cancer-I project.
For more information about the Conference: https://memea2022.ieee-ims.org/

Highlights

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

May 30, 2024

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Apr 29, 2024

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Open Call To Include New Beneficiaries Into The EUCAIM Consortium

Open Call To Include New Beneficiaries Into The EUCAIM Consortium

Apr 19, 2024

The EUCAIM project is launching an open call for new beneficiaries to join the consortium. The objective of the EUCAIM open call is to: i) onboard new cancer image data holders, increasing the geographic dimensions, data modalities or cancer targets, and  ii) include...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

Apr 11, 2024

ProCAncer-I will be organising the 3rd Dissemination Event at the 21st IEEE International Symposium on Biomedical Imaging, which will be held in Athens, Greece, May 27-30, 2024. ProCAncer-I will organise the Workshop “Integrating imaging Data and AI models for...

Stay in touch!